Retatrutide 20mg — Vial Spec, Reconstitution Math & COA

High-Mass Vial Specification & Laboratory Purpose

In experimental biochemistry and preclinical metabolic studies, the 20mg vial specification of retatrutide serves as a high-density reference standard. A single 20mg vial contains 20.0 milligrams of high-purity, lyophilized peptide cake formulated with precise buffer salts to preserve tertiary structure during freeze-drying. Principal investigators and laboratory technicians select 20mg unit sizes primarily to reduce intra-assay variance across high-throughput screening platforms, longitudinal animal models, and automated liquid handling pipelines.

When managing extensive animal cohorts or multi-well cell culture arrays, utilizing low-mass vials (such as 2mg or 5mg fills) introduces repeated reconstitution steps, increasing the risk of pipetting error, vial-to-vial mass variance, and contamination. The 20mg format allows research teams to prepare a single, unified master stock solution that can be aliquoted into single-use micro-tubes. This workflow ensures consistent concentration parameters across multi-week experimental runs, directly improving statistical power and assay reproducibility.

Catalog Availability & Custom Fill Options at PX1 Research

PX1 Research maintains a rigorous catalog of standardized peptide fill sizes to accommodate varying laboratory requirements. While our standard online inventory frequently features 5mg and 10mg unit sizes under our specialized GLP-3R product entry, high-mass configurations such as 20mg vials are regularly prepared for institutional laboratories requiring bulk single-vial reserves.

If a specific 20mg fill is not listed as immediately available in our active catalog, research facilities can examine our complete list of all research peptides or contact our synthesis team to coordinate custom fill schedules. Every unit distributed by PX1 Research—whether a standard catalog mass or a custom high-density run—undergoes identical cGMP-compliant lyophilization, mass spectrometry verification, and third-party laboratory testing before release.

Biochemical Target Profile: Triple Agonism (GCGR, GIPR, GLP-1R)

Retatrutide is a synthetic 39-amino-acid peptide engineered as a tri-agonist targeting three distinct peptide receptors involved in metabolic regulation: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR). Structural modifications include a backbone derived from the native GIP sequence, incorporated alpha-aminobutyric acid residues for protease resistance, and C18 fatty diacid acylation that facilitates non-covalent binding to serum albumin.

In vitro functional assays demonstrate that retatrutide exhibits high binding affinity across all three human and rodent receptor targets. Pharmacodynamic profiling reveals potencies expressed via EC50 values in cyclic AMP (cAMP) accumulation assays: potent activity at the human GIPR, moderate-to-high potency at GLP-1R, and balanced activation at GCGR. Preclinical animal studies utilize this triple-agonist profile to investigate synergistic downstream pathways, including lipid oxidation, energy expenditure modulation, hepatocyte fat accumulation, and glucose-dependent insulin secretion.

Precision Reconstitution Math for 20mg Fills

Accurate solubilization of a 20mg lyophilized cake requires precise volumetric calculations to establish desired working stock concentrations. Because 20mg represents a substantial peptide mass, diluent volume selection directly impacts solution viscosity, micropipette accuracy, and downstream dilution series. Researchers are encouraged to utilize our interactive reconstitution calculator to verify complex volumetric math prior to liquid handling.

The following mathematical references illustrate standard working concentrations achieved by adding specific volumes of sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline to a 20mg retatrutide vial:

1.0 mL Diluent Addition: 20.0 mg / 1.0 mL = 20.0 mg/mL concentration (20.0 μg/μL). This high-density stock is ideal for minimizing volumetric addition to cell culture wells or micro-osmotic pumps.

2.0 mL Diluent Addition: 20.0 mg / 2.0 mL = 10.0 mg/mL concentration (10.0 μg/μL). Recommended for general laboratory workflows requiring precise 10 μg increments per microliter.

3.0 mL Diluent Addition: 20.0 mg / 3.0 mL = 6.67 mg/mL concentration (6.67 μg/μL). Offers balanced liquid volume for standard sub-microliter micropipettes.

4.0 mL Diluent Addition: 20.0 mg / 4.0 mL = 5.0 mg/mL concentration (5.0 μg/μL). Preferred for rodent models where larger volumetric injection accuracy is necessary to mitigate margin-of-error issues in high-dose arms.

Aliquot Planning & Freeze-Thaw Mitigation Protocols

Once a 20mg retatrutide vial is reconstituted, repeated opening of the primary container and subjecting the liquid solution to multiple freeze-thaw cycles significantly accelerates peptide bond cleavage and aggregation. To maintain structural integrity over prolonged experimental windows, laboratories must implement a strict post-reconstitution aliquot protocol.

Immediately following gentle complete dissolution (without vortexing), the master stock should be partitioned using sterile, low-protein-binding polypropylene micro-centrifuge tubes. Aliquot volume should be calculated based on the daily or weekly consumption rate of the research project (e.g., 100 μL or 250 μL working fractions). Single-use aliquots intended for immediate use within 7 to 14 days should be maintained at 2°C to 8°C. Fractions designated for long-term storage must be flash-frozen and kept at -20°C or -80°C until needed. Once an individual aliquot is thawed, any remaining liquid should be consumed within the active assay window or discarded rather than refrozen.

Storage Dynamics: Lyophilized Powder vs. Solubilized Matrix

The physical stability of retatrutide depends heavily on ambient temperature, moisture exposure, and light conditions. In its lyophilized state, the peptide is highly stable due to the removal of water, which suppresses hydrolytic degradation pathways. Upon arrival at the laboratory facility, unopened lyophilized 20mg vials should be stored in a dark, desiccated freezer environment at -20°C for short-to-medium term storage, or -80°C for extended multi-year preservation.

Reconstituted liquid solutions are far more sensitive to temperature fluctuations and physical agitation. Thermal energy accelerates peptide hydrolysis, while excessive shear forces—such as vigorous shaking or high-speed vortexing—can induce irreversible aggregation and precipitation of the peptide chains. Reconstituted vials or aliquots must be handled gently, stored strictly between 2°C and 8°C in temperature-monitored laboratory refrigeration, and protected from light exposure using foil or amber storage containers.

Analytical Quality Assurance: Lot-Matched COA, HPLC, & Endotoxin Testing

High-mass research peptides require rigorous analytical validation to ensure that bulk production run purity standards match exact theoretical specifications. PX1 Research enforces a multi-tier quality control protocol for every synthesized lot. Research teams can directly review or download lot-specific documentation through our online certificate of analysis database.

Quality assurance verification for retatrutide 20mg vials incorporates three essential analytical methods:

High-Performance Liquid Chromatography (HPLC): Confirms chemical purity by measuring total chromatographic peak area. PX1 Research mandates a minimum threshold of >99.0% area purity, ensuring the absence of truncation sequences, deletion peptides, or residual synthesis byproducts.

Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular weight (monoisotopic mass ~4731.4 g/mol), confirming correct amino acid sequence identity and target acylation without structural adducts.

Limulus Amebocyte Lysate (LAL) Endotoxin Testing: Measures bacterial endotoxin levels to guarantee suitability for sensitive cell culture and animal models. All PX1 research compounds must register below strict internal limits (<0.01 EU/μg).

Comparative Analysis: Multi-Receptor Incretin Analogues

Evaluating multi-receptor agonists requires comparing their affinity profiles against established single- and dual-acting benchmark compounds within the incretin mimetic class. While single agonists such as semaglutide focus exclusively on GLP-1R activation, and dual agonists like tirzepatide engage both GLP-1R and GIPR, retatrutide introduces a third operational vector through glucagon receptor (GCGR) co-agonism. Additionally, novel combinations involving metabolic peptides like the amylin analogue cagrilintide are being explored in comparative preclinical frameworks.

The addition of GCGR engagement alters cellular energy expenditure pathways in rodent models, enhancing hepatic lipid clearance and thermogenesis compared to dual GIP/GLP-1 activation alone. By contrasting retatrutide against single and dual analogues in standardized in vitro assays, researchers can isolate the specific contribution of glucagon receptor signaling to intracellular cAMP accumulation and downstream gene expression profiles.

Vial Size Selection: Selecting 5mg, 10mg, or 20mg Fills for Laboratory Workflows

Choosing between a 5mg, 10mg, or 20mg vial configuration depends on specific experimental parameters, study duration, and storage capabilities. While 20mg vials offer maximum efficiency for high-volume research, smaller vial sizes provide distinct operational advantages for smaller-scale projects or pilot studies.

For preliminary binding assays, short-term cell culture studies, or initial dose-response curve mapping, 5mg or 10mg vials are often optimal. They allow researchers to minimize reconstituting excessive peptide volume that might remain unused past its 30-day refrigerated shelf life. Conversely, for continuous, multi-week animal studies, high-density cell culture screens, or institutional programs managing high sample throughput, ordering 20mg vials or establishing dedicated institutional accounts through our wholesale peptide program minimizes unit costs and guarantees lot consistency across the entire trial duration. For deeper mechanical context and study protocols, visit our centralized peptide research hub.